REGN Stock: Regeneron Pharmaceuticals, Inc. Stock Price, Analysis & Insights
Get live REGN stock price $610.32, comprehensive Regeneron Pharmaceuticals, Inc. stock analysis, charts, news, and expert forecast. Real-time REGN stock data and investment insights.
Loading chart data...
Regeneron Pharmaceuticals, Inc. (REGN) Overview
Regeneron Pharmaceuticals, Inc. (REGN) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, REGN trades at $610.32 with a market capitalization of 62.88B . Over the past 52 weeks, REGN has traded between $503.25 and $821.11 , with the current price positioned at approximately 34% of this range . The stock curr...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 62.88B
- Current price: $610.32
- 52-week range: $503.25 - $821.11
- P/E ratio: 14.89
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses. Its therapeutic portfolio includes EYLEA, ...
Company Information
- CEO
- Leonard S. Schleifer
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 15158
Contact Information
- Website
- https://www.regeneron.com
- Address
- 777 Old Saw Mill River Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 14.9)
✓ Lower volatility stock (Beta: 0.24) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Regeneron Pharmaceuticals, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Regeneron Pharmaceuticals, Inc.
- ⚠Investors should consider how Regeneron Pharmaceuticals, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
62.88B
P/E Ratio (TTM)
14.89
Beta
0.24
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare REGN with peer companies:
- Price
- $295.13
- Market cap
- 39.40B
- Price
- $877.78
- Market cap
- 54.32B
- Price
- $296.44
- Market cap
- 78.42B
- Price
- $282.40
- Market cap
- 54.94B
- Price
- $407.98
- Market cap
- 88.60B
- Price
- $24.74
- Market cap
- 15.19B
- Price
- $567.78
- Market cap
- 44.79B
- Price
- $106.84
- Market cap
- 21.34B
- Price
- $544.96
- Market cap
- 23.13B
- Price
- $82.03
- Market cap
- 34.39B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.